Hongyun Zhao

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Heat Shock Protein

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

NPJ precision oncology

Cell death & disease

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Shaoxing Guan, Xi Chen, Yuru Wei, Fei Wang, Wen Xie, Youhao Chen, Heng Liang, Xia Zhu, Yunpeng Yang, Wenfeng Fang, Yan Huang, Hongyun Zhao, Xiao-Xu Zhang, Shu Liu, Wei Zhuang, Min Huang, Xue-Ding Wang, Li Zhang
Germline USP36 Mutation Confers Resistance to EGFR-TKIs by Upregulating MLLT3 Expression in Patients with Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Shaoxing Guan, Xi Chen, Yuru Wei, Fei Wang, Wen Xie, Youhao Chen, Heng Liang, Xia Zhu, Yunpeng Yang, Wenfeng Fang, Yan Huang, Hongyun Zhao, Xiao-Xu Zhang, Shu Liu, Wei Zhuang, Min Huang, Xue-Ding Wang, Li Zhang
Germline USP36 mutation confers resistance to EGFR-TKIs by upregulating MLLT3 expression in non-small cell lung cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Shaoxing Guan, Xi Chen, Yuru Wei, Fei Wang, Wen Xie, Youhao Chen, Heng Liang, Xia Zhu, Yunpeng Yang, Wenfeng Fang, Yan Huang, Hongyun Zhao, Xiao-Xu Zhang, Shu Liu, Wei Zhuang, Min Huang, Xue-Ding Wang, Li Zhang
Germline USP36 Mutation Confers Resistance to EGFR-TKIs by Upregulating MLLT3 Expression in Patients with Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Jiaxin Cao, Kangmei Zeng, Qun Chen, Ting Yang, Feiteng Lu, Chaozhuo Lin, Jianhua Zhan, Wenjuan Ma, Ting Zhou, Yan Huang, Fan Luo, Hongyun Zhao
PQR309, a dual PI3K/mTOR inhibitor, synergizes with gemcitabine by impairing the GSK-3β and STAT3/HSP60 signaling pathways to treat nasopharyngeal carcinoma. Cell death & disease 15 (3) (2024)
Jiaxin Cao, Kangmei Zeng, Qun Chen, Ting Yang, Feiteng Lu, Chaozhuo Lin, Jianhua Zhan, Wenjuan Ma, Ting Zhou, Yan Huang, Fan Luo, Hongyun Zhao
PQR309, a dual PI3K/mTOR inhibitor, synergizes with gemcitabine by impairing the GSK-3β and STAT3/HSP60 signaling pathways to treat nasopharyngeal carcinoma. Cell death & disease 15 (3) (2024)
Yuxiang Ma, Hua-Qiang Zhou, Fan Luo, Yang Zhang, Changbin Zhu, Weiwei Li, Zhan Huang, Jingbo Zhao, Jinhui Xue, Yuanyuan Zhao, Wenfeng Fang, Yunpeng Yang, Yan Huang, Li Zhang, Hongyun Zhao
Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma. NPJ precision oncology 8 (1) (2024)
Yuxiang Ma, Hua-Qiang Zhou, Fan Luo, Yang Zhang, Changbin Zhu, Weiwei Li, Zhan Huang, Jingbo Zhao, Jinhui Xue, Yuanyuan Zhao, Wenfeng Fang, Yunpeng Yang, Yan Huang, Li Zhang, Hongyun Zhao
Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma. NPJ precision oncology 8 (1) (2024)
Jiaxin Cao, Kangmei Zeng, Qun Chen, Ting Yang, Feiteng Lu, Chaozhuo Lin, Jianhua Zhan, Wenjuan Ma, Ting Zhou, Yan Huang, Fan Luo, Hongyun Zhao
PQR309, a dual PI3K/mTOR inhibitor, synergizes with gemcitabine by impairing the GSK-3β and STAT3/HSP60 signaling pathways to treat nasopharyngeal carcinoma. Cell death & disease 15 (3) (2024)
Yuxiang Ma, Hua-Qiang Zhou, Fan Luo, Yang Zhang, Changbin Zhu, Weiwei Li, Zhan Huang, Jingbo Zhao, Jinhui Xue, Yuanyuan Zhao, Wenfeng Fang, Yunpeng Yang, Yan Huang, Li Zhang, Hongyun Zhao
Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma. NPJ precision oncology 8 (1) (2024)
Yuxiang Ma, Xin Zhao, Xi Chen, Xinxin Huang, Qingguang Lin, Yuehao Lin, Salvatore J Salamone, Xinlan Zhou, Changzheng Wang, Weiting Liang, Hongyun Zhao, Kui Wu, Yunpeng Yang, Li Zhang
Therapeutic drug monitoring of docetaxel by pharmacokinetics and pharmacogenetics: A randomized clinical trial of AUC-guided dosing in nonsmall cell lung cancer. Clinical and translational medicine 11 (4) (2022)
Pooja Anil Shah, Vaishnavi Sambandam, Anne M Fernandez, Hongyun Zhao, Tuhina Mazumdar, Li Shen, Qi Wang, Kazi M Ahmed, Soma Ghosh, Mitchell J Frederick, Jing Wang, Faye M Johnson
Sustained Aurora Kinase B Expression Confers Resistance to PI3K Inhibition in Head and Neck Squamous Cell Carcinoma. Cancer research 82 (23) (2022)